MetLife Investment Advisors LLC decreased its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 2.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,476 shares of the medical instruments supplier’s stock after selling 190 shares during the quarter. MetLife Investment Advisors LLC’s holdings in Mettler-Toledo International were worth $4,326,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Captrust Financial Advisors raised its position in Mettler-Toledo International by 306.7% during the 2nd quarter. Captrust Financial Advisors now owns 183 shares of the medical instruments supplier’s stock worth $106,000 after purchasing an additional 138 shares during the last quarter. Signaturefd LLC bought a new position in Mettler-Toledo International during the 1st quarter worth $111,000. Cornerstone Advisors Inc. raised its position in Mettler-Toledo International by 7,233.3% during the 2nd quarter. Cornerstone Advisors Inc. now owns 220 shares of the medical instruments supplier’s stock worth $127,000 after purchasing an additional 217 shares during the last quarter. Piedmont Investment Advisors LLC bought a new position in Mettler-Toledo International during the 2nd quarter worth $167,000. Finally, Gideon Capital Advisors Inc. bought a new position in Mettler-Toledo International during the 1st quarter worth $233,000. 92.89% of the stock is currently owned by institutional investors.

In other news, insider William P. Donnelly sold 500 shares of Mettler-Toledo International stock in a transaction dated Thursday, August 16th. The stock was sold at an average price of $570.00, for a total value of $285,000.00. Following the completion of the transaction, the insider now directly owns 1,500 shares of the company’s stock, valued at approximately $855,000. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Shawn Vadala sold 300 shares of Mettler-Toledo International stock in a transaction dated Thursday, September 6th. The stock was sold at an average price of $590.00, for a total value of $177,000.00. Following the completion of the transaction, the chief financial officer now directly owns 5,599 shares of the company’s stock, valued at $3,303,410. The disclosure for this sale can be found here. Over the last three months, insiders sold 18,358 shares of company stock valued at $10,744,204. Corporate insiders own 4.80% of the company’s stock.

Shares of NYSE:MTD opened at $606.04 on Wednesday. The firm has a market cap of $15.38 billion, a P/E ratio of 34.49, a P/E/G ratio of 2.34 and a beta of 1.11. The company has a debt-to-equity ratio of 1.92, a current ratio of 1.46 and a quick ratio of 1.06. Mettler-Toledo International Inc. has a 12-month low of $540.24 and a 12-month high of $697.26.

Mettler-Toledo International (NYSE:MTD) last announced its earnings results on Thursday, July 26th. The medical instruments supplier reported $4.65 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $4.58 by $0.07. Mettler-Toledo International had a return on equity of 90.80% and a net margin of 13.52%. The business had revenue of $722.00 million during the quarter, compared to analyst estimates of $715.69 million. During the same period last year, the company earned $3.92 EPS. Mettler-Toledo International’s revenue for the quarter was up 10.4% compared to the same quarter last year. analysts expect that Mettler-Toledo International Inc. will post 20.15 earnings per share for the current fiscal year.

Several research analysts recently issued reports on the company. JPMorgan Chase & Co. raised their target price on Mettler-Toledo International from $550.00 to $600.00 and gave the stock a “neutral” rating in a research report on Friday, July 27th. Morgan Stanley lowered their target price on Mettler-Toledo International from $540.00 to $529.00 and set an “equal weight” rating for the company in a research report on Friday, July 27th. Finally, Zacks Investment Research raised Mettler-Toledo International from a “sell” rating to a “hold” rating in a research report on Monday, July 30th. Ten analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $625.55.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.

Featured Story: Book Value Per Share – BVPS

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International Inc. (NYSE:MTD).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.